| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |